Wei Gu et al. reported that BU could reversed MDR in human hepatocellular carcinoma cells through multiple pathways, including inhibit drug efflux function via down-regulation of MRP1, induce apoptosis and arrested the cell cycle at the G0/G1 phase. Here, ABCC1 is linked to hepatocellular carcinoma.